ENCYSIVE PHARMACEUTICALS
Encysive Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes synthetic and small molecule compounds to address medical needs worldwide. The company focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade, and vascular diseases. Its products include Argatroban for the treatment of heparin-induced thrombocytopenia; and Thelin (sitaxsentan sodium), an endothelin r... eceptor antagonist for the treatment of pulmonary arterial hypertension, congestive heart failure, and essential hypertension. The company's clinical development compounds include TBC3711, an endothelin receptor antagonist; TBC4746, an antigen-4 antagonist; ENC8003, a G protein-coupled receptor; and bimosiamose, a selectin antagonist. Encysive Pharmaceuticals has research collaboration and license agreements with GlaxoSmithKline plc; Mitsubishi Pharma Corporation; Schering-Plough, Ltd.; Schering Corporation; and Revotar Biopharmaceuticals, AG. The company was founded in 1989. It was formerly known as Texas Biotechnology Corporation and changed its name to Encysive Pharmaceuticals, Inc. in 2003. Encysive Pharmaceuticals is based in Houston, Texas. As of June 10, 2008, Encysive Pharmaceuticals Inc. operates as a subsidiary of Pfizer Inc.
ENCYSIVE PHARMACEUTICALS
Industry:
Biotechnology Medical Pharmaceutical
Founded:
1989-01-01
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.encysive.com
Total Employee:
101+
Status:
Active
Total Funding:
88.95 M USD
Technology used in webpage:
Nginx Energy Group Hosting
Similar Organizations
i2 Pharmaceuticals
i2 Pharmaceuticals, a biopharmaceutical company.
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Investors List
Hudson Capital Group
Hudson Capital Group investment in Private Equity Round - Encysive Pharmaceuticals
Enable Capital Management
Enable Capital Management investment in Private Equity Round - Encysive Pharmaceuticals
Azimuth Opportunity
Azimuth Opportunity investment in Private Equity Round - Encysive Pharmaceuticals
Official Site Inspections
http://www.encysive.com
- Host name: ec2-3-94-41-167.compute-1.amazonaws.com
- IP address: 3.94.41.167
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Encysive Pharmaceuticals"
Encysive Pharmaceuticals - Crunchbase Company …
Encysive Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes synthetic and small molecule compounds to …See details»
Organization | Encysive
Encysive Report issue. Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4. Founded: Houston TX United States ... Organization Overview. First Clinical Trial. 2002 …See details»
Pfizer Completes Tender Offer for Shares of Encysive …
As a result of this merger, Encysive will become a wholly-owned subsidiary of Pfizer Inc., and each share of Encysive ’ s outstanding common stock will be cancelled and (except for shares …See details»
Encysive Pharmaceuticals Inc - Company Profile and News
Company profile page for Encysive Pharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»
Encysive Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Explore Encysive Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 5 clinical trials, 2 news, and 69 literature, Disease Domain:Nervous System …See details»
Encysive Pharmaceuticals Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Encysive Pharmaceuticals Inc. of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»
Pfizer Completes Acquisition of Encysive Pharmaceuticals Inc.
Jun 9, 2008 Encysive is now a wholly-owned subsidiary of Pfizer. In the merger, each share of Encysive ’ s outstanding common stock was cancelled and (except for shares held by …See details»
Encysive Pharmaceuticals - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors ... obfuscated — Oct 19, 2006: Private Equity Round - Encysive …See details»
Encysive Pharmaceuticals - PitchBook
Encysive Pharmaceuticals was acquired on 12-Jun-2008. Who acquired Encysive Pharmaceuticals? Encysive Pharmaceuticals was acquired by Pfizer (Pharmaceuticals). Data …See details»
Encysive Pharmaceuticals - Crunchbase
Encysive Pharmaceuticals develops synthetic and small molecule compounds to address medical needs worldwide.See details»
Encysive Pharmaceuticals Announces Clinical Organizational …
Jun 26, 2006 Encysive Pharmaceuticals Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of novel, synthetic, small molecule compounds …See details»
Pfizer Completes Acquisition of Encysive Pharmaceuticals Inc.
85.33% of the outstanding Encysive shares by tender offer. Encysive's common stock will cease to be traded on the NASDAQ Global Market by the close of the market today. Pfizer has …See details»
Pfizer to acquire Encysive Pharmaceuticals for $195M
The Board of Directors of Encysive has unanimously approved the merger agreement and unanimously recommends that Encysive stockholders accept the tender offer and tender their …See details»
Encysive Pharmaceuticals - Products, Competitors, Financials, …
Encysive Pharmaceuticals Inc. Use the CB Insights Platform to explore Encysive Pharmaceuticals's full profile. Encysive Pharmaceuticals - Products, Competitors, Financials, …See details»
Pfizer To Acquire Encysive Pharmaceuticals
The Board of Directors of Encysive has unanimously approved the merger agreement and unanimously recommends that Encysive stockholders accept the tender offer and tender their …See details»
Pfizer Successfully Completes Tender Offer for Shares of Encysive ...
Mar 31, 2008 Thereafter, Encysive ’ s common stock will cease to be traded on the NASDAQ Global Market. If Pfizer, through Explorer Acquisition Corp., owns at least 90% of the …See details»
Pfizer Inc. Completes Acquisition of Encysive Pharmaceuticals
Jun 10, 2008 Pfizer Inc. Completes Acquisition of Encysive Pharmaceuticals Published: Jun 10, 2008 NEW YORK--(BUSINESS WIRE)--Pfizer Inc (NYSE:PFE) today announced that it has …See details»
Encysive Canada Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Encysive Canada Inc of Toronto, ON. Get the latest business insights from Dun & Bradstreet.See details»
Bimosiamose - Drug Targets, Indications, Patents - Synapse
Selectins, a family of cell adhesion molecules, are involved in leukocyte extravasation to sites of inflammation. We investigated the safety and efficacy of the inhaled pan-selectin antagonist …See details»
Pfizer to Acquire Encysive Pharmaceuticals
The Board of Directors of Encysive has unanimously approved the merger agreement and unanimously recommends that Encysive stockholders accept the tender offer and tender their …See details»